RXDX
Prometheus Biosciences, Inc. Common Stock
RXDX
RXDX
Delisted
RXDX was delisted on the 15th of June, 2023.
49 hedge funds and large institutions have $585M invested in Prometheus Biosciences, Inc. Common Stock in 2021 Q2 according to their latest regulatory filings, with 22 funds opening new positions, 9 increasing their positions, 10 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
10% less repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 10
Holders
49
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$14.6M | |
| 2 | +$10.3M | |
| 3 | +$5.25M | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$4.74M |
| 5 |
State Street
Boston,
Massachusetts
|
+$3.83M |
Top Sellers
| 1 | -$9.59M | |
| 2 | -$6.02M | |
| 3 | -$4.57M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$3.52M |
| 5 |
Millennium Management
New York
|
-$3.4M |